XML 24 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Redeemable Noncontrolling Interest and Stockholders' Equity - USD ($)
$ in Thousands
Total
Cumulative effect adjustment
Redeemable Noncontrolling Interest
Common Stock 
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative effect adjustment
Accumulated Other Comprehensive Gain (Loss)
  Accumulated Deficit
  Accumulated Deficit
Cumulative effect adjustment
Beginning balance at Dec. 31, 2020     $ 57,100            
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Adjustment of redeemable noncontrolling interest $ (20,900)   20,900         $ (20,900)  
Reclassification of redeemable noncontrolling interest to noncontrolling interest liability     (78,000)            
Ending balance at Dec. 31, 2021     0            
Beginning balance (in shares) at Dec. 31, 2020       100,213,985          
Beginning balance at Dec. 31, 2020 $ 1,298,495     $ 1 $ 1,902,389   $ 2,697 (606,592)  
Beginning balance (Accounting Standards Update 2020-06) at Dec. 31, 2020   $ (325,966)       $ (330,403)     $ 4,437
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock upon exercise of stock options (in shares) 693,074     693,074          
Issuance of common stock upon exercise of stock options $ 8,112       8,112        
Vesting of restricted stock units (in shares)       750,160          
Vesting of common stock exercised early 52       52        
Issuance of common stock under employee stock purchase plan (in shares)       110,227          
Issuance of common stock under employee stock purchase plan 9,753       9,753        
Taxes paid related to net share settlement of restricted stock units (83,759)       (83,759)        
Stock-based compensation 151,449       151,449        
Adjustment of redeemable noncontrolling interest (20,900)   20,900         (20,900)  
Other comprehensive (loss) income, net of tax impact (7,461)           (7,461)    
Net loss (384,770)             (384,770)  
Ending balance (in shares) at Dec. 31, 2021       101,767,446          
Ending balance at Dec. 31, 2021 $ 645,005     $ 1 1,657,593   (4,764) (1,007,825)  
Ending balance at Dec. 31, 2022     0            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock upon exercise of stock options (in shares) 228,311     228,311          
Issuance of common stock upon exercise of stock options $ 2,625       2,625        
Vesting of restricted stock units (in shares)       315,673          
Vesting of common stock exercised early 8       8        
Issuance of common stock under employee stock purchase plan (in shares)       307,953          
Issuance of common stock under employee stock purchase plan 9,316       9,316        
Taxes paid related to net share settlement of restricted stock units (7,878)       (7,878)        
Stock-based compensation 94,685       94,685        
Tender offer issued in connection with the Joint Venture Acquisition and acquisition related costs (14,235)       (14,235)        
Other comprehensive (loss) income, net of tax impact (14,758)           (14,758)    
Net loss (654,588)             (654,588)  
Ending balance (in shares) at Dec. 31, 2022       102,619,383          
Ending balance at Dec. 31, 2022 60,180     $ 1 1,742,114   (19,522) (1,662,413)  
Ending balance at Dec. 31, 2023     $ 0            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock upon follow-on offering, net of offering costs (in shares)       14,375,000          
Issuance of common stock upon follow-on offering, net of offering costs 381,369       381,369        
Issuance of common stock upon registered direct offering (in shares)       3,387,446          
Issuance of common stock upon registered direct offering $ 90,616       90,616        
Issuance of common stock upon exercise of stock options (in shares) 51,124     51,124          
Issuance of common stock upon exercise of stock options $ 405       405        
Vesting of restricted stock units (in shares)       732,038          
Issuance of common stock under employee stock purchase plan (in shares)       464,870          
Issuance of common stock under employee stock purchase plan 10,154       10,154        
Taxes paid related to net share settlement of restricted stock units (11,197)       (11,197)        
Stock-based compensation 90,759       90,759        
Other comprehensive (loss) income, net of tax impact 15,847           15,847    
Net loss (479,449)             (479,449)  
Ending balance (in shares) at Dec. 31, 2023       121,629,861          
Ending balance at Dec. 31, 2023 $ 158,684     $ 1 $ 2,304,220   $ (3,675) $ (2,141,862)